S

Sanofi

Global pharma company; vaccines and R&D

Vaccines Head of Marketing

Full-TimeDeadline 10/31/26
No salary listed
Expert
Bachelor's, MBA
Beijing, China
In Person
Growth & MarketingMarketing Generalist & Management

About the job

Requirements
  • A bachelor's degree or above in sales, marketing, or a related field.
  • At least 10 years of sales, marketing, and strategic planning experience in a similar position in the pharmaceutical industry.
  • A proven track record in leading, coaching, and developing a sales organization.
  • Knowledge of the key technical and functional skills needed for the role, different types of business propositions, and how businesses operate.
  • Ability to learn new methods and technical skills easily.
  • Strong cross-functional work experience and ability to influence others.
  • Knowledge of the pharmaceutical industry and its products.
  • Strong communication, negotiation, and presentation skills, including persuasive verbal and written communication.
  • Learning agility, proactivity, self-motivation, analytical and problem-solving ability, creative thinking, and a results-oriented attitude.
  • Ability to work and deliver results in a dynamic, fast-paced team environment.
  • Strong people leadership and interpersonal skills.
  • Strategic mindset.
  • Fluency in spoken and written English and Chinese.
Responsibilities
  • Define marketing strategy blueprints for all products currently in the China market to elevate long-term product brand image.
  • Develop and implement the annual marketing plan, contribute to the ten-year Country Strategic Plan, and propose a three-year budget plan.
  • Lead and drive cross-functional marketing activities to achieve annual financial objectives and agreed long-term objectives.
  • Assess market trends, improve analytics usage for decision-making, and identify short- and long-term opportunities.
  • Manage the company’s key product and image, maintain relationships with customers and relevant government authorities, and ensure business plans and marketing programs are implemented to a high standard.
  • Work with cross-functional teams to execute marketing programs and promotional activities and events.
  • Develop new customer segments, channels, initiatives, and ways to reach customers to support business growth and business-model evolution.
  • Develop innovative customer engagement models and marketing solutions, including advancing digital marketing through expertise and guidance.
  • Integrate company and brand resources to maximize returns on resource investments.
  • Develop the Innovation Center’s strategy and industry reputation, manage public relations, engage key opinion leaders, and plan showcase events and budgets.
  • Research and evaluate innovation collaboration opportunities, advise management, drive project implementation, monitor progress, and report outcomes to leadership and stakeholders.
  • Formulate consumer education strategies and consumer promotion and marketing activities across channels, ensuring consistent strategies across products.
  • Coordinate cross-functional resources and lead innovation in consumer marketing activities, including digital marketing, to raise public awareness of relevant disease areas and support business development.
  • Support product marketing to deliver expected results aligned with company strategy and financial objectives.
  • Anticipate environmental changes and plan accordingly.
  • Provide strategic advice to internal and external partners for the Beyfortus cooperation alliance.
  • Develop team structures and workflows, and allocate resources to align with business priorities and marketing objectives.
  • Identify skill gaps and lead recruitment to strengthen the marketing organization and capabilities.
  • Mentor and coach team members to support talent development and career growth.
  • Facilitate communication between marketing and other departments, build stakeholder relationships, advocate for marketing priorities, and secure resources.
  • Ensure team behavior complies with applicable requirements.
Desired Qualifications
  • Healthcare-related education is preferred.
  • An MBA background is preferred.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • Parental Leave

Company News

Associated Press
Oct 19th, 2026
Enable Injections wins first Japan approval for enFuse on-body injector via Sanofi's CirCLIQ

Enable Injections has won its first commercial product approval in Japan. The country's Ministry of Health, Labour and Welfare approved the company's enFuse On-Body Delivery System through Sanofi's CirCLIQ Injector. The device delivers a subcutaneous form of Sarclisa (isatuximab) with the push of a button, for treating multiple myeloma. It is the first anticancer treatment given through an on-body injector in Japan. The approval follows recent clearances in the US and Europe. Japan approved Sarclisa SC in June 2026, backed by the IRAKLIA phase 3 study, which showed the subcutaneous form was non-inferior to intravenous delivery. "We're proud to partner with Sanofi to bring our enFuse technology to patients in Japan," said Michael D. Hooven, chairman and chief executive officer of Enable.

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...